Indefinite Delivery Contract SPE2DX15D5017

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC, which runs through November 2026, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, and infectious disease prevention.

The IDC does not have a set-aside designation, indicating open competition. Numerous delivery orders have been issued under this IDC, valued up to $203,850.00, for the delivery of these critical medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation covering similar pharmaceutical and medical products. These IDCs enable efficient government procurement of essential healthcare supplies for military personnel, veterans, and other federal beneficiaries.